Evaluating the impact of including non-randomised studies of interventions in meta-analysis of randomised controlled trials: a protocol for a meta-epidemiological study
暂无分享,去创建一个
Xin Sun | M. Briel | J. Busse | Ling Li | K. Zou | Minghong Yao | Guowei Li | Yun-Juan Wang | F. Mei
[1] Xin Sun,et al. Methods for the Inclusion of Real-World Evidence in a Rare Events Meta-Analysis of Randomized Controlled Trials , 2023, Journal of clinical medicine.
[2] T. Wilt,et al. Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program. , 2022, Journal of clinical epidemiology.
[3] Louis C. Harms,et al. Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study , 2022, BMC Medicine.
[4] P. Lurie,et al. Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study , 2022, BMJ.
[5] Louis C. Harms,et al. An Empirical Evaluation of the Impact Scenario of Pooling Bodies of Evidence from Randomized Controlled Trials and Cohort Studies in Nutrition Research. , 2022, Advances in nutrition.
[6] R. Willke,et al. Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials , 2021, BMC Medicine.
[7] G. Guyatt,et al. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines , 2021, Journal of clinical epidemiology.
[8] J. Meerpohl,et al. Evaluating agreement between bodies of evidence from randomised controlled trials and cohort studies in nutrition research: meta-epidemiological study , 2021, BMJ.
[9] J. Gamble,et al. Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors and The Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events. , 2021, American journal of epidemiology.
[10] Grammati Sarri,et al. Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making , 2020, BMJ Evidence-Based Medicine.
[11] Pablo Emilio Verde,et al. A bias‐corrected meta‐analysis model for combining, studies of different types and quality , 2020, Biometrical journal. Biometrische Zeitschrift.
[12] W. Bolislis,et al. Use of real-world data for new drug applications and line extensions. , 2020, Clinical therapeutics.
[13] S. Toh,et al. Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions , 2020, Pharmacoepidemiology and drug safety.
[14] F. Tubach,et al. Meta-analyses frequently pooled different study types together: a meta-epidemiological study. , 2019, Journal of clinical epidemiology.
[15] P. Tugwell,et al. Including non‐randomized studies on intervention effects , 2019, Cochrane Handbook for Systematic Reviews of Interventions.
[16] Natalie S Blencowe,et al. RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.
[17] K. Abrams,et al. Methods for the inclusion of real-world evidence in network meta-analysis , 2018, BMC Medical Research Methodology.
[18] Xin Sun,et al. Real world evidence: experience and lessons from China , 2018, British Medical Journal.
[19] L. Tang,et al. Real world evidence: experience and lessons from China , 2018, British Medical Journal.
[20] P. Tugwell,et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.
[21] R. Califf,et al. Real-World Evidence - What Is It and What Can It Tell Us? , 2016, The New England journal of medicine.
[22] David Moher,et al. Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study , 2016, PLoS medicine.
[23] P. Ravaud,et al. Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review , 2016, BMC Medical Research Methodology.
[24] 野間 久史. Individual Participant Dataに基づくメタアナリシス , 2014 .
[25] L. Bero,et al. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. , 2014, The Cochrane database of systematic reviews.
[26] Robert L Grant,et al. Converting an odds ratio to a range of plausible relative risks for better communication of research findings , 2014, BMJ : British Medical Journal.
[27] Lisa Hartling,et al. Quality of reporting in systematic reviews of adverse events: systematic review , 2014, BMJ : British Medical Journal.
[28] T. Trikalinos,et al. Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. , 2012, European heart journal.
[29] David R. Jones,et al. Methodology and reporting of systematic reviews and meta-analyses of observational studies in psychiatric epidemiology: systematic review. , 2012, The British journal of psychiatry : the journal of mental science.
[30] P. Shekelle,et al. Observational studies in systematic [corrected] reviews of comparative effectiveness: AHRQ and the Effective Health Care Program. , 2011, Journal of clinical epidemiology.
[31] Su Golder,et al. Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview , 2011, PLoS medicine.
[32] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[33] David Moher,et al. Epidemiology and Reporting Characteristics of Systematic Reviews , 2007, PLoS medicine.
[34] S. Golder,et al. Room for improvement? A survey of the methods used in systematic reviews of adverse effects , 2006, BMC Medical Research Methodology.
[35] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[36] S. Barton,et al. Which clinical studies provide the best evidence? , 2000, BMJ : British Medical Journal.